LENZ
Price
$4.11Alerts
Change
+$0.01 (+0.24%)
Updated
Nov 11 closing price
Capitalization
109.97M
132 days until earnings call
Intraday BUY SELL Signals
PLUR
Price
$1.14Alerts
Change
+$0.02 (+1.79%)
Updated
Nov 11 closing price
Capitalization
14.57M
Intraday BUY SELL Signals
Interact to see
Advertisement

LENZ vs PLUR

LENZ vs PLUR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LENZ vs. PLUR commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LENZ is a StrongBuy and PLUR is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for LENZ with price predictions
Nov 11, 2026

LENZ's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for LENZ turned positive on October 09, 2026. Looking at past instances where LENZ's MACD turned positive, the stock continued to rise in 48 of 54 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where LENZ's RSI Oscillator exited the oversold zone, 24 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on LENZ as a result. In 71 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.

LENZ moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +42.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where LENZ advanced for three days, in 234 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LENZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

LENZ broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for LENZ entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.502) is normal, around the industry mean (3.498). P/E Ratio (-0.847) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (5.903) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. LENZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LENZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for PLUR with price predictions
Nov 11, 2026

PLUR's RSI Indicator recovers from oversold territory

The RSI Oscillator for PLUR moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 29 similar instances when the indicator left oversold territory. In 27 of the 29 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 61 cases where PLUR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.

PLUR moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PLUR crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 74%.

Following a +9.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where PLUR advanced for three days, in 166 of 219 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PLUR as a result. In 101 of 109 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLUR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

PLUR broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PLUR entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.632) is normal, around the industry mean (3.498). P/E Ratio (-0.484) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (10.650) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. PLUR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PLUR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
PLUR: Fundamental Ratings
PLUR
OUTLOOK RATING
1..100
45
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LENZPLUR
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 16 days ago
76%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (LENZ: $4.11 vs. PLUR: $1.14)
Brand notoriety: LENZ and PLUR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LENZ: 50% vs. PLUR: 118%
Market capitalization -- LENZ: $109.97M vs. PLUR: $14.57M
LENZ [@Biotechnology] is valued at $109.97M. PLUR’s [@Biotechnology] market capitalization is $14.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LENZ’s FA Score shows that 1 FA rating(s) are green while PLUR’s FA Score has 2 green FA rating(s).

  • LENZ’s FA Score: 1 green, 4 red.
  • PLUR’s FA Score: 2 green, 3 red.
According to our system of comparison, both LENZ and PLUR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LENZ’s TA Score shows that 5 TA indicator(s) are bullish while PLUR’s TA Score has 5 bullish TA indicator(s).

  • LENZ’s TA Score: 5 bullish, 4 bearish.
  • PLUR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both LENZ and PLUR are a good buy in the short-term.

Price Growth

LENZ (@Biotechnology) experienced а +18.79% price change this week, while PLUR (@Biotechnology) price change was -7.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.49%. For the same industry, the average monthly price growth was -6.84%, and the average quarterly price growth was -13.86%.

Reported Earning Dates

LENZ is expected to report earnings on Mar 24, 2027.

Industries' Descriptions

@Biotechnology (-0.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with BEAM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
+0.24%
BEAM - LENZ
40%
Loosely correlated
+2.62%
MIST - LENZ
40%
Loosely correlated
N/A
ANIX - LENZ
39%
Loosely correlated
-9.15%
MNPR - LENZ
38%
Loosely correlated
-0.07%
BHVN - LENZ
38%
Loosely correlated
+0.53%
More

PLUR and

Correlation & Price change

A.I.dvisor tells us that PLUR and KOD have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLUR and KOD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLUR
1D Price
Change %
PLUR100%
+1.79%
KOD - PLUR
29%
Poorly correlated
+1.18%
ENSC - PLUR
29%
Poorly correlated
+0.03%
LENZ - PLUR
28%
Poorly correlated
+0.24%
MGNX - PLUR
26%
Poorly correlated
-4.13%
STRO - PLUR
26%
Poorly correlated
+0.88%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASTI1.530.01
+0.66%
Ascent Solar Technologies Inc
CHT49.030.22
+0.45%
CHUNGHWA TELECOM CO Ltd
SLGN41.50-0.30
-0.72%
Silgan Holdings
GLUE10.31-0.19
-1.81%
Monte Rosa Therapeutics
NATR10.31-0.62
-5.67%
Nature's Sunshine Products